hVIVO
A world leader in providing human challenge studies to test infectious and respiratory products
Founded in 1989 by John Oxford, a leading influenza expert and professor at Queen Mary, the company has grown to become the world leader in providing human challenge studies to test infectious and respiratory products.
In 2024, hVIVO launched their flagship Canary Wharf site — the world’s largest commercial human challenge trial facility — housing 50 quarantine bedrooms, advanced laboratories, an outpatient unit, and corporate headquarters.
With BSL-3 capability, this site allows hVIVO to offer complex trials, advanced laboratory support, and expanded clinical services.
hVIVO aim to transform global healthcare by revolutionising the drug development process through scientific ingenuity.
Prof John Oxford
Emeritus Professor of Virology
